×
Time:2025-10-09
Recently, the All-China Federation of Industry and Commerce released the “Top 500 Private Enterprises by Invention Patents 2025” and “Top 500 Private Enterprises by R&D Investment 2025”. NHU Holding Group once again earned a place on both prestigious lists.
Our robust R&D capabilities and solid patent portfolio have secured our continued recognition, highlighting our innovative vitality and strong growth momentum within the industry. This dual achievement reflects our long-term dedication to our core business, our steadfast focus on industrial development, and our active alignment with national strategies. It also reaffirms our pioneering spirit and unwavering commitment to technological innovation and intellectual property protection.
For more than three decades, NHU has been deeply engaged in fine chemicals, pharmaceuticals, equipment, and education, continuously strengthening the innovation, industrial, and value chains. Each year, we invest heavily in cutting-edge technology research and product development. Over the past five years, we have invested 5.506 billion yuan in R&D, averaging over 5% of our annual sales revenue.
In fine chemicals, NHU has achieved breakthroughs in key technologies that have long constrained the development of vitamin E, vitamin A, PPS, and methionine. In pharmaceuticals, we have established strong product portfolios in cardiovascular and diabetes therapeutics, while advancing research into innovative small nucleic acid drugs.
By the end of 2024, NHU held 1,020 valid domestic patents and 129 valid international patents. In addition, research outcomes from our university collaborations have received one China Patent Gold Award and one Silver Award, reinforcing our commitment to building a solid foundation for sustainable development.
The China National Intellectual Property Administration (CNIPA) recently announced the winners of the 26th China Patent Awards. NHU’s invention patent, “A Clean Method for the Preparation of D,L-Methionine,” stood out among numerous entries for its outstanding technological innovation and significant industrial value, earning the company another China Patent Silver Award. To date, NHU has received two China Patent Gold Awards, two Silver Awards, and six Merit Awards.
View details
The aquafeed market has been highly volatile in recent months. With fishmeal prices remaining elevated and supplies increasingly tight, the cost pressures associated with high-fishmeal formulations continue to weigh on both feed manufacturers and aquaculture producers. To mitigate these pressures, the industry has increasingly turned to alternative protein sources—including plant, insect and microbial proteins—and adopted low-fishmeal formulations.
View details
On June 27, the seventh Yue Health Lecture Series, hosted by the Shaoxing Health Management Association, co-hosted by the Shaoxing Medical Association, and organized by NHU, was held in Xinchang.
View details